Affiliation:
1. Department of Neurology, Harvard Medical School, and the Pediatric Epilepsy Program, Massachusetts General Hospital, Boston, MA,
Abstract
Epilepsy is very common in tuberous sclerosis complex and occurs in 80 to 90% of affected individuals during their lifetime. Onset usually occurs during childhood, and up to one third of children with tuberous sclerosis complex will develop infantile spasms. Although not completely understood, the incidence of epilepsy is thought to relate to the neuropathologic features of the disorder, including cortical tubers and other dysgenetic features. Individuals with tuberous sclerosis complex frequently have epileptiform features to their electroencephalograms. Treatment of epilepsy in tuberous sclerosis complex is similar to epilepsy resulting from other causes and includes anticonvulsant medications, the vagus nerve stimulator, and the ketogenic diet. Vigabatrin has been shown to be particularly effective in treating infantile spasms in the setting of tuberous sclerosis complex. Epilepsy surgery has a very important role in the management of children and adults with pharmacoresistant epilepsy in tuberous sclerosis complex. ( J Child Neurol 2004;19:680—686).
Subject
Clinical Neurology,Pediatrics, Perinatology, and Child Health
Reference62 articles.
1. Epidemiology of Tuberous Sclerosis
2. Identification and characterization of the tuberous sclerosis gene on chromosome 16
3. Identification of the Tuberous Sclerosis Gene
TSC1
on Chromosome 9q34
4. Gomez MR: Natural history of cerebral tuberous sclerosis, in Gomez MR, Sampson JR, Whittemore VH (eds): Tuberous Sclerosis Complex: Developmental Perspectives in Psychiatry, 3rd ed. New York, Oxford University Press, 1999, 29—46.
Cited by
172 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献